<?xml version="1.0" encoding="UTF-8"?>
<p id="par0265">As regards the uncertainty of some aspects of the treatment of COVID-19, the criteria for initiating treatment without an established indication are, besides the immediate impossibility of carrying out clinical trials, are evidence of safety from animal models, adequate risk-benefit analyses by research ethics committees and informed consent by patients or their legal guardians.</p>
